Data on nutritional markers (body mass index [BMI], albumin, total cholesterol) were collected at baseline and then assessed at 16 weeks; change from baseline was compared between the two groups.
Ability Pharmaceuticals has announced that the Food and Drug Administration has granted orphan drug designation to ABTL0812, an investigational candidate for pancreatic cancer.
For patients with type 2 diabetes mellitus (T2DM), use of statins offsets insulin-related cancer risks, according to research published online in the Journal of Internal Medicine.
Scientists who discovered that pancreatic cancer is at least four separate diseases say their findings could lead to improved treatments for the disease.
A new international, multicenter study has found that incretin-based drugs, used to treat type 2 diabetes, are not associated with an increased risk of pancreatic cancer.
Metformin may inhibit the progression of pancreatic cancer by decreasing inflammation and fibrosis, a study published in PLOS One reported.